Detalhe da pesquisa
1.
A phase I/II study of the combination of quizartinib with azacitidine or low-dose cytarabine for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome.
Haematologica
; 106(8): 2121-2130, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33853292